Cargando…

Non-drug Therapies for Alzheimer’s Disease: A Review

Alzheimer’s disease (AD) is a debilitating disease leading to great social and economic burdens worldwide. During the past decades, increasing understanding of this disease enables dynamic trials for disease interventions. Unfortunately, at present, AD still remains uncurable, and therefore, develop...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Xianqian, Ji, Min, Zhang, Hongmei, Liu, Zunjian, Chai, Yujing, Cheng, Qi, Yang, Yue, Cordato, Dennis, Gao, Jianqun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9837368/
https://www.ncbi.nlm.nih.gov/pubmed/36376734
http://dx.doi.org/10.1007/s40120-022-00416-x
_version_ 1784869061271748608
author Li, Xianqian
Ji, Min
Zhang, Hongmei
Liu, Zunjian
Chai, Yujing
Cheng, Qi
Yang, Yue
Cordato, Dennis
Gao, Jianqun
author_facet Li, Xianqian
Ji, Min
Zhang, Hongmei
Liu, Zunjian
Chai, Yujing
Cheng, Qi
Yang, Yue
Cordato, Dennis
Gao, Jianqun
author_sort Li, Xianqian
collection PubMed
description Alzheimer’s disease (AD) is a debilitating disease leading to great social and economic burdens worldwide. During the past decades, increasing understanding of this disease enables dynamic trials for disease interventions. Unfortunately, at present, AD still remains uncurable, and therefore, developing intervention strategies for improving symptoms and slowing down the disease process becomes a practical focus in parallel with searching for a disease-modifying medication. The aim of this review is to summarize the outcomes of AD clinical trials of non-drug therapies published in the past decade, including cognitive-oriented interventions, physical exercise interventions, brain stimulation, as well as nutrition supplementations, to find out the most effective interventions in the category by looking through the primary and secondary outcomes. The outcomes of the trials could be varied with the interventional approaches, the tested cohorts, the settings of observing outcomes, and the duration of follow-ups, which are all discussed in this review. Hence, we hope to provide crucial information for application of these interventions in real-world settings and assist with optimization of clinical trial designs in this area.
format Online
Article
Text
id pubmed-9837368
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Healthcare
record_format MEDLINE/PubMed
spelling pubmed-98373682023-02-08 Non-drug Therapies for Alzheimer’s Disease: A Review Li, Xianqian Ji, Min Zhang, Hongmei Liu, Zunjian Chai, Yujing Cheng, Qi Yang, Yue Cordato, Dennis Gao, Jianqun Neurol Ther Review Alzheimer’s disease (AD) is a debilitating disease leading to great social and economic burdens worldwide. During the past decades, increasing understanding of this disease enables dynamic trials for disease interventions. Unfortunately, at present, AD still remains uncurable, and therefore, developing intervention strategies for improving symptoms and slowing down the disease process becomes a practical focus in parallel with searching for a disease-modifying medication. The aim of this review is to summarize the outcomes of AD clinical trials of non-drug therapies published in the past decade, including cognitive-oriented interventions, physical exercise interventions, brain stimulation, as well as nutrition supplementations, to find out the most effective interventions in the category by looking through the primary and secondary outcomes. The outcomes of the trials could be varied with the interventional approaches, the tested cohorts, the settings of observing outcomes, and the duration of follow-ups, which are all discussed in this review. Hence, we hope to provide crucial information for application of these interventions in real-world settings and assist with optimization of clinical trial designs in this area. Springer Healthcare 2022-11-14 /pmc/articles/PMC9837368/ /pubmed/36376734 http://dx.doi.org/10.1007/s40120-022-00416-x Text en © The Author(s) 2022 https://creativecommons.org/licenses/by-nc/4.0/Open AccessThis article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Review
Li, Xianqian
Ji, Min
Zhang, Hongmei
Liu, Zunjian
Chai, Yujing
Cheng, Qi
Yang, Yue
Cordato, Dennis
Gao, Jianqun
Non-drug Therapies for Alzheimer’s Disease: A Review
title Non-drug Therapies for Alzheimer’s Disease: A Review
title_full Non-drug Therapies for Alzheimer’s Disease: A Review
title_fullStr Non-drug Therapies for Alzheimer’s Disease: A Review
title_full_unstemmed Non-drug Therapies for Alzheimer’s Disease: A Review
title_short Non-drug Therapies for Alzheimer’s Disease: A Review
title_sort non-drug therapies for alzheimer’s disease: a review
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9837368/
https://www.ncbi.nlm.nih.gov/pubmed/36376734
http://dx.doi.org/10.1007/s40120-022-00416-x
work_keys_str_mv AT lixianqian nondrugtherapiesforalzheimersdiseaseareview
AT jimin nondrugtherapiesforalzheimersdiseaseareview
AT zhanghongmei nondrugtherapiesforalzheimersdiseaseareview
AT liuzunjian nondrugtherapiesforalzheimersdiseaseareview
AT chaiyujing nondrugtherapiesforalzheimersdiseaseareview
AT chengqi nondrugtherapiesforalzheimersdiseaseareview
AT yangyue nondrugtherapiesforalzheimersdiseaseareview
AT cordatodennis nondrugtherapiesforalzheimersdiseaseareview
AT gaojianqun nondrugtherapiesforalzheimersdiseaseareview